GeneDx Holdings Corp. (NASDAQ: WGSWW) Stock Competitors & Peer Comparison
See WGSWW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for WGSWW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| WGSWW | $0.00 | +0.00% | 5.8K | -0.00 | -$1.01 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.63% |
| TMO | $674.21 | -0.12% | 250.9B | 29.30 | $23.16 | +0.27% |
| DHR | $224.45 | -0.02% | 159.9B | 28.50 | $7.98 | +0.63% |
| NTRA | $411.85 | -0.17% | 59B | -311.95 | -$1.32 | N/A |
| A | $174.94 | +1.24% | 49.5B | 30.15 | $5.81 | +0.58% |
| IQV | $268.57 | -0.67% | 44.6B | 22.32 | $12.13 | N/A |
| WAT | $441.58 | +1.85% | 43.5B | 32.38 | $13.68 | N/A |
| IDXX | $530.13 | +2.09% | 41.7B | 37.21 | $14.22 | N/A |
| ILMN | $268.83 | -0.43% | 41.1B | 54.06 | $5.03 | N/A |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
WGSWW vs DHR-PB Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, WGSWW's ROE is -0.39%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, WGSWW is less volatile compared to DHR-PB. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
WGSWW vs TMO Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, TMO has a market cap of 250.9B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while TMO trades at $674.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas TMO's P/E ratio is 29.30. In terms of profitability, WGSWW's ROE is -0.39%, compared to TMO's ROE of +0.13%. Regarding short-term risk, WGSWW is less volatile compared to TMO. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
WGSWW vs DHR Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, DHR has a market cap of 159.9B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while DHR trades at $224.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas DHR's P/E ratio is 28.50. In terms of profitability, WGSWW's ROE is -0.39%, compared to DHR's ROE of +0.08%. Regarding short-term risk, WGSWW is less volatile compared to DHR. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check DHR's competition here
Natera, Inc. (NASDAQ: NTRA)
WGSWW vs NTRA Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, NTRA has a market cap of 59B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while NTRA trades at $411.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas NTRA's P/E ratio is -311.95. In terms of profitability, WGSWW's ROE is -0.39%, compared to NTRA's ROE of -0.12%. Regarding short-term risk, WGSWW is less volatile compared to NTRA. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check NTRA's competition here
Agilent Technologies, Inc. (NYSE: A)
WGSWW vs A Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, A has a market cap of 49.5B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while A trades at $174.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas A's P/E ratio is 30.15. In terms of profitability, WGSWW's ROE is -0.39%, compared to A's ROE of +0.20%. Regarding short-term risk, WGSWW is less volatile compared to A. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check A's competition here
IQVIA Holdings Inc. (NYSE: IQV)
WGSWW vs IQV Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, IQV has a market cap of 44.6B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while IQV trades at $268.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas IQV's P/E ratio is 22.32. In terms of profitability, WGSWW's ROE is -0.39%, compared to IQV's ROE of +0.22%. Regarding short-term risk, WGSWW is less volatile compared to IQV. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check IQV's competition here
Waters Corporation (NYSE: WAT)
WGSWW vs WAT Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, WAT has a market cap of 43.5B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while WAT trades at $441.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas WAT's P/E ratio is 32.38. In terms of profitability, WGSWW's ROE is -0.39%, compared to WAT's ROE of +0.02%. Regarding short-term risk, WGSWW is less volatile compared to WAT. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check WAT's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
WGSWW vs IDXX Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, IDXX has a market cap of 41.7B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while IDXX trades at $530.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas IDXX's P/E ratio is 37.21. In terms of profitability, WGSWW's ROE is -0.39%, compared to IDXX's ROE of +0.72%. Regarding short-term risk, WGSWW is less volatile compared to IDXX. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check IDXX's competition here
Illumina, Inc. (NASDAQ: ILMN)
WGSWW vs ILMN Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, ILMN has a market cap of 41.1B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while ILMN trades at $268.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas ILMN's P/E ratio is 54.06. In terms of profitability, WGSWW's ROE is -0.39%, compared to ILMN's ROE of +0.31%. Regarding short-term risk, WGSWW is less volatile compared to ILMN. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check ILMN's competition here
Mettler-Toledo International Inc. (NYSE: MTD)
WGSWW vs MTD Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, MTD has a market cap of 31.2B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while MTD trades at $1,527.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas MTD's P/E ratio is 35.50. In terms of profitability, WGSWW's ROE is -0.39%, compared to MTD's ROE of -12.00%. Regarding short-term risk, WGSWW is less volatile compared to MTD. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check MTD's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
WGSWW vs DGX Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, DGX has a market cap of 26.2B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while DGX trades at $233.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas DGX's P/E ratio is 23.44. In terms of profitability, WGSWW's ROE is -0.39%, compared to DGX's ROE of +0.14%. Regarding short-term risk, WGSWW is less volatile compared to DGX. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check DGX's competition here
Labcorp Holdings Inc. (NYSE: LH)
WGSWW vs LH Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, LH has a market cap of 25.4B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while LH trades at $307.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas LH's P/E ratio is 18.37. In terms of profitability, WGSWW's ROE is -0.39%, compared to LH's ROE of +0.12%. Regarding short-term risk, WGSWW is less volatile compared to LH. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check LH's competition here
Guardant Health, Inc. (NASDAQ: GH)
WGSWW vs GH Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, GH has a market cap of 23.8B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while GH trades at $175.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas GH's P/E ratio is -50.81. In terms of profitability, WGSWW's ROE is -0.39%, compared to GH's ROE of +2.11%. Regarding short-term risk, WGSWW is less volatile compared to GH. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
WGSWW vs EXAS Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas EXAS's P/E ratio is -95.37. In terms of profitability, WGSWW's ROE is -0.39%, compared to EXAS's ROE of -0.09%. Regarding short-term risk, WGSWW is similarly volatile compared to EXAS. This indicates similar risk in terms of short-term price fluctuations for WGSWW.Check EXAS's competition here
Medpace Holdings, Inc. (NASDAQ: MEDP)
WGSWW vs MEDP Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, MEDP has a market cap of 17.2B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while MEDP trades at $617.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas MEDP's P/E ratio is 36.10. In terms of profitability, WGSWW's ROE is -0.39%, compared to MEDP's ROE of +1.10%. Regarding short-term risk, WGSWW is less volatile compared to MEDP. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check MEDP's competition here
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV)
WGSWW vs ILMNV Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while ILMNV trades at $107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas ILMNV's P/E ratio is N/A. In terms of profitability, WGSWW's ROE is -0.39%, compared to ILMNV's ROE of N/A. Regarding short-term risk, WGSWW is similarly volatile compared to ILMNV. This indicates similar risk in terms of short-term price fluctuations for WGSWW.Check ILMNV's competition here
Revvity, Inc. (NYSE: RVTY)
WGSWW vs RVTY Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, RVTY has a market cap of 16.8B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while RVTY trades at $151.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas RVTY's P/E ratio is 28.22. In terms of profitability, WGSWW's ROE is -0.39%, compared to RVTY's ROE of +0.03%. Regarding short-term risk, WGSWW is less volatile compared to RVTY. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check RVTY's competition here
PerkinElmer, Inc. (NYSE: PKI)
WGSWW vs PKI Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas PKI's P/E ratio is 41.45. In terms of profitability, WGSWW's ROE is -0.39%, compared to PKI's ROE of +0.03%. Regarding short-term risk, WGSWW is less volatile compared to PKI. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check PKI's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
WGSWW vs CRL Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, CRL has a market cap of 14.2B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while CRL trades at $291.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas CRL's P/E ratio is 29.77. In terms of profitability, WGSWW's ROE is -0.39%, compared to CRL's ROE of -0.08%. Regarding short-term risk, WGSWW is less volatile compared to CRL. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check CRL's competition here
ICON Public Limited Company (NASDAQ: ICLR)
WGSWW vs ICLR Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, ICLR has a market cap of 13.4B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while ICLR trades at $170.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas ICLR's P/E ratio is 14.32. In terms of profitability, WGSWW's ROE is -0.39%, compared to ICLR's ROE of +0.04%. Regarding short-term risk, WGSWW is less volatile compared to ICLR. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check ICLR's competition here
Qiagen N.V. (NYSE: QGEN)
WGSWW vs QGEN Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, QGEN has a market cap of 9.3B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while QGEN trades at $44.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas QGEN's P/E ratio is 18.60. In terms of profitability, WGSWW's ROE is -0.39%, compared to QGEN's ROE of +0.12%. Regarding short-term risk, WGSWW is less volatile compared to QGEN. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check QGEN's competition here
GRAIL Inc. (NASDAQ: GRAL)
WGSWW vs GRAL Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, GRAL has a market cap of 5.7B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while GRAL trades at $133.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas GRAL's P/E ratio is -13.60. In terms of profitability, WGSWW's ROE is -0.39%, compared to GRAL's ROE of -0.16%. Regarding short-term risk, WGSWW is less volatile compared to GRAL. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check GRAL's competition here
RadNet, Inc. (NASDAQ: RDNT)
WGSWW vs RDNT Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, RDNT has a market cap of 5.6B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while RDNT trades at $69.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas RDNT's P/E ratio is 156.11. In terms of profitability, WGSWW's ROE is -0.39%, compared to RDNT's ROE of -0.02%. Regarding short-term risk, WGSWW is less volatile compared to RDNT. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check RDNT's competition here
BillionToOne, Inc. (NASDAQ: BLLN)
WGSWW vs BLLN Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, BLLN has a market cap of 5.6B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while BLLN trades at $121.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas BLLN's P/E ratio is 173.89. In terms of profitability, WGSWW's ROE is -0.39%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, WGSWW is less volatile compared to BLLN. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check BLLN's competition here
Sotera Health Company (NASDAQ: SHC)
WGSWW vs SHC Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, SHC has a market cap of 5.3B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while SHC trades at $18.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas SHC's P/E ratio is 19.22. In terms of profitability, WGSWW's ROE is -0.39%, compared to SHC's ROE of +0.27%. Regarding short-term risk, WGSWW is less volatile compared to SHC. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check SHC's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
WGSWW vs SYNH Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas SYNH's P/E ratio is 61.40. In terms of profitability, WGSWW's ROE is -0.39%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, WGSWW is less volatile compared to SYNH. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check SYNH's competition here
Veracyte, Inc. (NASDAQ: VCYT)
WGSWW vs VCYT Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, VCYT has a market cap of 3.6B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while VCYT trades at $45.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas VCYT's P/E ratio is 22.62. In terms of profitability, WGSWW's ROE is -0.39%, compared to VCYT's ROE of +0.09%. Regarding short-term risk, WGSWW is less volatile compared to VCYT. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check VCYT's competition here
CareDx, Inc (NASDAQ: CDNA)
WGSWW vs CDNA Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, CDNA has a market cap of 3.3B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while CDNA trades at $63.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas CDNA's P/E ratio is 76.90. In terms of profitability, WGSWW's ROE is -0.39%, compared to CDNA's ROE of +0.33%. Regarding short-term risk, WGSWW is less volatile compared to CDNA. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check CDNA's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
WGSWW vs OLK Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas OLK's P/E ratio is -96.59. In terms of profitability, WGSWW's ROE is -0.39%, compared to OLK's ROE of -0.07%. Regarding short-term risk, WGSWW is less volatile compared to OLK. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check OLK's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
WGSWW vs WGS Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, WGS has a market cap of 2.6B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while WGS trades at $77.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas WGS's P/E ratio is 238.69. In terms of profitability, WGSWW's ROE is -0.39%, compared to WGS's ROE of -0.39%. Regarding short-term risk, WGSWW is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check WGS's competition here
Personalis, Inc. (NASDAQ: PSNL)
WGSWW vs PSNL Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, PSNL has a market cap of 1.7B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while PSNL trades at $16.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas PSNL's P/E ratio is -14.97. In terms of profitability, WGSWW's ROE is -0.39%, compared to PSNL's ROE of -0.46%. Regarding short-term risk, WGSWW is less volatile compared to PSNL. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check PSNL's competition here
OPKO Health, Inc. (NASDAQ: OPK)
WGSWW vs OPK Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, OPK has a market cap of 1.2B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while OPK trades at $1.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas OPK's P/E ratio is -6.04. In terms of profitability, WGSWW's ROE is -0.39%, compared to OPK's ROE of -0.06%. Regarding short-term risk, WGSWW is less volatile compared to OPK. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check OPK's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
WGSWW vs CSTL Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, CSTL has a market cap of 1.1B. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while CSTL trades at $34.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas CSTL's P/E ratio is -54.44. In terms of profitability, WGSWW's ROE is -0.39%, compared to CSTL's ROE of -0.04%. Regarding short-term risk, WGSWW is less volatile compared to CSTL. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check CSTL's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
WGSWW vs FLGT Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, FLGT has a market cap of 635M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while FLGT trades at $22.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas FLGT's P/E ratio is 2236.00. In terms of profitability, WGSWW's ROE is -0.39%, compared to FLGT's ROE of -0.08%. Regarding short-term risk, WGSWW is less volatile compared to FLGT. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check FLGT's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
WGSWW vs GRALV Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas GRALV's P/E ratio is N/A. In terms of profitability, WGSWW's ROE is -0.39%, compared to GRALV's ROE of N/A. Regarding short-term risk, WGSWW is less volatile compared to GRALV. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check GRALV's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
WGSWW vs NEO Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, NEO has a market cap of 495.7M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while NEO trades at $18.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas NEO's P/E ratio is 148.38. In terms of profitability, WGSWW's ROE is -0.39%, compared to NEO's ROE of -0.06%. Regarding short-term risk, WGSWW is less volatile compared to NEO. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check NEO's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
WGSWW vs MYGN Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, MYGN has a market cap of 400.5M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while MYGN trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas MYGN's P/E ratio is -32.62. In terms of profitability, WGSWW's ROE is -0.39%, compared to MYGN's ROE of -0.33%. Regarding short-term risk, WGSWW is less volatile compared to MYGN. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check MYGN's competition here
Global Cord Blood Corporation (NYSE: CO)
WGSWW vs CO Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas CO's P/E ratio is 5.06. In terms of profitability, WGSWW's ROE is -0.39%, compared to CO's ROE of +0.11%. Regarding short-term risk, WGSWW is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check CO's competition here
Standard BioTools Inc. (NASDAQ: FLDM)
WGSWW vs FLDM Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas FLDM's P/E ratio is -4.74. In terms of profitability, WGSWW's ROE is -0.39%, compared to FLDM's ROE of +0.18%. Regarding short-term risk, WGSWW is less volatile compared to FLDM. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check FLDM's competition here
Biodesix, Inc. (NASDAQ: BDSX)
WGSWW vs BDSX Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, BDSX has a market cap of 247.6M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while BDSX trades at $29.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas BDSX's P/E ratio is -9.60. In terms of profitability, WGSWW's ROE is -0.39%, compared to BDSX's ROE of -7.88%. Regarding short-term risk, WGSWW is less volatile compared to BDSX. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check BDSX's competition here
Exagen Inc. (NASDAQ: XGN)
WGSWW vs XGN Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, XGN has a market cap of 204.9M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while XGN trades at $8.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas XGN's P/E ratio is -10.47. In terms of profitability, WGSWW's ROE is -0.39%, compared to XGN's ROE of -1.22%. Regarding short-term risk, WGSWW is less volatile compared to XGN. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check XGN's competition here
Freenome, Inc. (NASDAQ: FRNM)
WGSWW vs FRNM Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, FRNM has a market cap of 132.1M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while FRNM trades at $15.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas FRNM's P/E ratio is N/A. In terms of profitability, WGSWW's ROE is -0.39%, compared to FRNM's ROE of N/A. Regarding short-term risk, WGSWW is less volatile compared to FRNM. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check FRNM's competition here
Genetron Holdings Limited (NASDAQ: GTH)
WGSWW vs GTH Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas GTH's P/E ratio is -1.11. In terms of profitability, WGSWW's ROE is -0.39%, compared to GTH's ROE of -1.01%. Regarding short-term risk, WGSWW is less volatile compared to GTH. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check GTH's competition here
Genetic Technologies Limited (NASDAQ: GENE)
WGSWW vs GENE Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas GENE's P/E ratio is -38.25. In terms of profitability, WGSWW's ROE is -0.39%, compared to GENE's ROE of -1.85%. Regarding short-term risk, WGSWW is similarly volatile compared to GENE. This indicates similar risk in terms of short-term price fluctuations for WGSWW.Check GENE's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
WGSWW vs IMDX Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, IMDX has a market cap of 102.7M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while IMDX trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas IMDX's P/E ratio is -2.13. In terms of profitability, WGSWW's ROE is -0.39%, compared to IMDX's ROE of +2.72%. Regarding short-term risk, WGSWW is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check IMDX's competition here
Sera Prognostics, Inc. (NASDAQ: SERA)
WGSWW vs SERA Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, SERA has a market cap of 77.1M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while SERA trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas SERA's P/E ratio is -3.11. In terms of profitability, WGSWW's ROE is -0.39%, compared to SERA's ROE of -0.47%. Regarding short-term risk, WGSWW is less volatile compared to SERA. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check SERA's competition here
Precipio, Inc. (NASDAQ: PRPO)
WGSWW vs PRPO Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, PRPO has a market cap of 43M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while PRPO trades at $23.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas PRPO's P/E ratio is -37.09. In terms of profitability, WGSWW's ROE is -0.39%, compared to PRPO's ROE of -0.08%. Regarding short-term risk, WGSWW is less volatile compared to PRPO. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check PRPO's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
WGSWW vs QUCY Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, QUCY has a market cap of 31.2M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while QUCY trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas QUCY's P/E ratio is -0.06. In terms of profitability, WGSWW's ROE is -0.39%, compared to QUCY's ROE of -3.65%. Regarding short-term risk, WGSWW is less volatile compared to QUCY. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check QUCY's competition here
MDxHealth S.A. (NASDAQ: MDXH)
WGSWW vs MDXH Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, MDXH has a market cap of 28.1M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while MDXH trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas MDXH's P/E ratio is -0.75. In terms of profitability, WGSWW's ROE is -0.39%, compared to MDXH's ROE of +1.43%. Regarding short-term risk, WGSWW is less volatile compared to MDXH. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check MDXH's competition here
Akumin Inc. (NASDAQ: AKU)
WGSWW vs AKU Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas AKU's P/E ratio is -0.13. In terms of profitability, WGSWW's ROE is -0.39%, compared to AKU's ROE of -5.32%. Regarding short-term risk, WGSWW is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check AKU's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
WGSWW vs BNR Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, BNR has a market cap of 18.6M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while BNR trades at $18.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas BNR's P/E ratio is -20.26. In terms of profitability, WGSWW's ROE is -0.39%, compared to BNR's ROE of -0.13%. Regarding short-term risk, WGSWW is less volatile compared to BNR. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check BNR's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
WGSWW vs CEMI Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas CEMI's P/E ratio is -0.63. In terms of profitability, WGSWW's ROE is -0.39%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, WGSWW is similarly volatile compared to CEMI. This indicates similar risk in terms of short-term price fluctuations for WGSWW.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
WGSWW vs ENZ Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas ENZ's P/E ratio is -2.24. In terms of profitability, WGSWW's ROE is -0.39%, compared to ENZ's ROE of -0.39%. Regarding short-term risk, WGSWW is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check ENZ's competition here
Psychemedics Corporation (NASDAQ: PMD)
WGSWW vs PMD Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas PMD's P/E ratio is -5.24. In terms of profitability, WGSWW's ROE is -0.39%, compared to PMD's ROE of -0.32%. Regarding short-term risk, WGSWW is similarly volatile compared to PMD. This indicates similar risk in terms of short-term price fluctuations for WGSWW.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
WGSWW vs ME Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas ME's P/E ratio is -0.03. In terms of profitability, WGSWW's ROE is -0.39%, compared to ME's ROE of -42.03%. Regarding short-term risk, WGSWW is similarly volatile compared to ME. This indicates similar risk in terms of short-term price fluctuations for WGSWW.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
WGSWW vs MYNZ Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, WGSWW's ROE is -0.39%, compared to MYNZ's ROE of -1.80%. Regarding short-term risk, WGSWW is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check MYNZ's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
WGSWW vs CHEK Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas CHEK's P/E ratio is -0.43. In terms of profitability, WGSWW's ROE is -0.39%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, WGSWW is less volatile compared to CHEK. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check CHEK's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
WGSWW vs BIAFW Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, BIAFW has a market cap of 9.8M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while BIAFW trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas BIAFW's P/E ratio is 1.04. In terms of profitability, WGSWW's ROE is -0.39%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, WGSWW is less volatile compared to BIAFW. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check BIAFW's competition here
Centogene N.V. (NASDAQ: CNTG)
WGSWW vs CNTG Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas CNTG's P/E ratio is -0.23. In terms of profitability, WGSWW's ROE is -0.39%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, WGSWW is similarly volatile compared to CNTG. This indicates similar risk in terms of short-term price fluctuations for WGSWW.Check CNTG's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
WGSWW vs ADVB Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, ADVB has a market cap of 9.3M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while ADVB trades at $6.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas ADVB's P/E ratio is -61.18. In terms of profitability, WGSWW's ROE is -0.39%, compared to ADVB's ROE of -0.21%. Regarding short-term risk, WGSWW is less volatile compared to ADVB. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check ADVB's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
WGSWW vs NDRA Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, NDRA has a market cap of 7.5M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while NDRA trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas NDRA's P/E ratio is -0.88. In terms of profitability, WGSWW's ROE is -0.39%, compared to NDRA's ROE of -2.25%. Regarding short-term risk, WGSWW is less volatile compared to NDRA. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check NDRA's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
WGSWW vs APDN Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas APDN's P/E ratio is -0.10. In terms of profitability, WGSWW's ROE is -0.39%, compared to APDN's ROE of -7.23%. Regarding short-term risk, WGSWW is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check APDN's competition here
Invitae Corporation (NYSE: NVTA)
WGSWW vs NVTA Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas NVTA's P/E ratio is -0.00. In terms of profitability, WGSWW's ROE is -0.39%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, WGSWW is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check NVTA's competition here
LumiraDx Limited (NASDAQ: LMDXW)
WGSWW vs LMDXW Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, WGSWW's ROE is -0.39%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, WGSWW is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check LMDXW's competition here
LumiraDx Limited (NASDAQ: LMDX)
WGSWW vs LMDX Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas LMDX's P/E ratio is -0.01. In terms of profitability, WGSWW's ROE is -0.39%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, WGSWW is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check LMDX's competition here
DermTech, Inc. (NASDAQ: DMTK)
WGSWW vs DMTK Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas DMTK's P/E ratio is -0.04. In terms of profitability, WGSWW's ROE is -0.39%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, WGSWW is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check DMTK's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
WGSWW vs BIAF Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, BIAF has a market cap of 3.1M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while BIAF trades at $6.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas BIAF's P/E ratio is -0.87. In terms of profitability, WGSWW's ROE is -0.39%, compared to BIAF's ROE of -2.57%. Regarding short-term risk, WGSWW is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check BIAF's competition here
Inotiv, Inc. (NASDAQ: NOTV)
WGSWW vs NOTV Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas NOTV's P/E ratio is -0.03. In terms of profitability, WGSWW's ROE is -0.39%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, WGSWW is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check NOTV's competition here
SeqLL Inc. (NASDAQ: SQL)
WGSWW vs SQL Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas SQL's P/E ratio is -0.40. In terms of profitability, WGSWW's ROE is -0.39%, compared to SQL's ROE of -30.46%. Regarding short-term risk, WGSWW is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check SQL's competition here
Aspira Women's Health Inc. (NASDAQ: AWH)
WGSWW vs AWH Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas AWH's P/E ratio is -0.09. In terms of profitability, WGSWW's ROE is -0.39%, compared to AWH's ROE of +1.62%. Regarding short-term risk, WGSWW is similarly volatile compared to AWH. This indicates similar risk in terms of short-term price fluctuations for WGSWW.Check AWH's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
WGSWW vs HTGM Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas HTGM's P/E ratio is -0.03. In terms of profitability, WGSWW's ROE is -0.39%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, WGSWW is similarly volatile compared to HTGM. This indicates similar risk in terms of short-term price fluctuations for WGSWW.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
WGSWW vs BIOC Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas BIOC's P/E ratio is -0.01. In terms of profitability, WGSWW's ROE is -0.39%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, WGSWW is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check BIOC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
WGSWW vs SQLLW Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, WGSWW's ROE is -0.39%, compared to SQLLW's ROE of -30.46%. Regarding short-term risk, WGSWW is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check SQLLW's competition here
iSpecimen Inc. (NASDAQ: ISPC)
WGSWW vs ISPC Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, ISPC has a market cap of 165.2K. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while ISPC trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas ISPC's P/E ratio is -0.04. In terms of profitability, WGSWW's ROE is -0.39%, compared to ISPC's ROE of -5.24%. Regarding short-term risk, WGSWW is less volatile compared to ISPC. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check ISPC's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
WGSWW vs BNGOW Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas BNGOW's P/E ratio is N/A. In terms of profitability, WGSWW's ROE is -0.39%, compared to BNGOW's ROE of -0.79%. Regarding short-term risk, WGSWW is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check BNGOW's competition here
Danaher Corporation (NYSE: DHR-PA)
WGSWW vs DHR-PA Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, WGSWW's ROE is -0.39%, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, WGSWW is less volatile compared to DHR-PA. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check DHR-PA's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
WGSWW vs CHEKZ Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, WGSWW's ROE is -0.39%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, WGSWW is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check CHEKZ's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
WGSWW vs PRXL Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, PRXL has a market cap of 0. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas PRXL's P/E ratio is 42.97. In terms of profitability, WGSWW's ROE is -0.39%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, WGSWW is less volatile compared to PRXL. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check PRXL's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
WGSWW vs OCDX Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, OCDX has a market cap of 0. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas OCDX's P/E ratio is -42.28. In terms of profitability, WGSWW's ROE is -0.39%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, WGSWW is less volatile compared to OCDX. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check OCDX's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
WGSWW vs MEUSW Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas MEUSW's P/E ratio is N/A. In terms of profitability, WGSWW's ROE is -0.39%, compared to MEUSW's ROE of -42.03%. Regarding short-term risk, WGSWW is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check MEUSW's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
WGSWW vs NDRAW Comparison September 2026
GeneDx Holdings Corp. (NASDAQ: WGSWW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGSWW stands at 5.8K. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, WGSWW is priced at $0.00 on the NASDAQ, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGSWW currently has a P/E ratio of -0.00, whereas NDRAW's P/E ratio is N/A. In terms of profitability, WGSWW's ROE is -0.39%, compared to NDRAW's ROE of -2.25%. Regarding short-term risk, WGSWW is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for WGSWW.Check NDRAW's competition here